Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Inhibrx Biosciences, Inc. | 15,000 | reported | 01 Apr 2025 | tx 2+190,000 |
| Inhibrx, Inc. | 0 | reported | 30 May 2024 | tx 20+120,000−235,061 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Apr 2025 | GRANT_AWARD | Inhibrx Biosciences, Inc. | 15,000 | 0.00 USD | deriv |
| 30 May 2024 | GRANT_AWARD | Inhibrx Biosciences, Inc. | 175,000 | 0.00 USD | deriv |
| 30 May 2024 | OTHER | Inhibrx, Inc. | 14,583 | — | deriv |
| 30 May 2024 | OTHER | Inhibrx, Inc. | 9,167 | — | deriv |
| 30 May 2024 | OTHER | Inhibrx, Inc. | 21,250 | — | deriv |
| 06 May 2024 | EXERCISE | Inhibrx, Inc. | 17,624 | 34.24 USD | deriv |
| 06 May 2024 | EXERCISE | Inhibrx, Inc. | 2,087 | 34.24 USD | deriv |
| 26 Mar 2024 | EXERCISE | Inhibrx, Inc. | 625 | 35.40 USD | deriv |
| 26 Mar 2024 | EXERCISE | Inhibrx, Inc. | 1,459 | 35.40 USD | deriv |
| 26 Mar 2024 | EXERCISE | Inhibrx, Inc. | 396 | 35.40 USD | deriv |
| 26 Mar 2024 | EXERCISE | Inhibrx, Inc. | 416 | 35.40 USD | deriv |
| 20 Mar 2024 | EXERCISE | Inhibrx, Inc. | 16,777 | 35.02 USD | deriv |
| 21 Mar 2024 | EXERCISE | Inhibrx, Inc. | 3,113 | 35.09 USD | deriv |
| 22 Mar 2024 | EXERCISE | Inhibrx, Inc. | 110 | 35.00 USD | deriv |
| 13 Mar 2024 | EXERCISE | Inhibrx, Inc. | 32,431 | 35.43 USD | deriv |
| 08 Mar 2024 | EXERCISE | Inhibrx, Inc. | 42,523 | 35.75 USD | deriv |
| 05 Mar 2024 | EXERCISE | Inhibrx, Inc. | 10,417 | 35.72 USD | deriv |
| 04 Mar 2024 | EXERCISE | Inhibrx, Inc. | 8,125 | 35.60 USD | deriv |
| 04 Mar 2024 | EXERCISE | Inhibrx, Inc. | 53,958 | 35.40 USD | deriv |
| 03 Jan 2023 | GRANT_AWARD | Inhibrx, Inc. | 30,000 | 0.00 USD | deriv |
| 11 Jan 2022 | GRANT_AWARD | Inhibrx, Inc. | 20,000 | 0.00 USD | deriv |
| 15 Jan 2021 | GRANT_AWARD | Inhibrx, Inc. | 70,000 | 0.00 USD | deriv |